Company No:
Contents
2022 | 2021 | |||
£ | £ | |||
Current assets | ||||
Debtors | 3 |
|
|
|
Cash at bank and in hand |
|
|
||
28,195 | 49,760 | |||
Creditors: amounts falling due within one year | 4 | (
|
(
|
|
Net current liabilities | (31,453) | (29,990) | ||
Total assets less current liabilities | (31,453) | (29,990) | ||
Net liabilities | (
|
(
|
||
Capital and reserves | ||||
Called-up share capital |
|
|
||
Profit and loss account | (
|
(
|
||
Total shareholder's deficit | (
|
(
|
Directors' responsibilities:
The financial statements of Injury Assess Limited (registered number:
A Keeling
Director |
The principal accounting policies are summarised below. They have all been applied consistently throughout the financial year and to the preceding financial year, unless otherwise stated.
Injury Assess Limited (the Company) is a private company, limited by shares, incorporated in the United Kingdom under the Companies Act 2006 and is registered in England and Wales. The address of the Company's registered office is Lancashire Gate, 21 Tiviot Dale, Stockport, SK1 1TD, United Kingdom. The principal place of business is 5 Woodcote View, Wilmslow, SK9 2DT.
The financial statements have been prepared under the historical cost convention, modified to include certain items at fair value, and in accordance with Section 1A of Financial Reporting Standard 102 (FRS 102) ‘The Financial Reporting Standard applicable in the UK and Republic of Ireland’ issued by the Financial Reporting Council and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime.
The financial statements are presented in pounds sterling which is the functional currency of the Company and rounded to the nearest £.
The company generated a loss for the year of £1,463 (2021: loss £40,093).
At 31 December 2022, the company had net current liabilities and net liabilities of £31,453 (2021: £29,990).
The directors have assessed the Balance Sheet and likely future cash flows at the date of approving these financial statements. The directors have a reasonable expectation that the Company has adequate resources to continue in operational existence and to meet its financial obligations as they fall due for at least 12 months from the date of signing these financial statements. Accordingly, they continue to adopt the going concern basis in preparing the financial statements.
Current tax is provided at amounts expected to be paid (or recoverable) using the tax rates and laws that have been enacted or substantively enacted at the Balance Sheet date.
Revenue is recognised to the extent that it is probable that the economic benefits will flow to the Company and the revenue can be reliably measured. The following criteria must also be met before revenue is recognised:
Turnover is derived from intermediation between medical professionals and legal teams on behalf of solicitors.
Revenue is measured at the fair value of invoices raised in respect of physiotherapy and medical appointments, net of discounts and excluding value added tax, and is recognised at the date the appointment is booked.
Assets, other than those measured at fair value, are assessed for indicators of impairment at each Balance Sheet date. If there is objective evidence of impairment, an impairment loss is recognised in the Statement of Income and Retained Earnings as described below.
The Company only enters into basic financial instrument transactions that result in the recognition of financial assets and liabilities like trade and other debtors and creditors, loans from banks and other third parties, loans to related parties and investments in ordinary shares.
2022 | 2021 | ||
Number | Number | ||
Monthly average number of persons employed by the Company during the year |
|
|
The directors did not receive any remuneration in the year (2021: £nil).
2022 | 2021 | ||
£ | £ | ||
Trade debtors |
|
|
|
Amounts owed by Group undertakings |
|
|
|
Other debtors |
|
|
|
|
|
2022 | 2021 | ||
£ | £ | ||
Trade creditors |
|
|
|
Accruals |
|
|
|
Corporation tax |
|
|
|
|
|
Transactions with the entity's directors
During the year advances of £3,535 (2021: £4,750) were paid to Mr D Keeling. The maximum advanced during the year was £3,535 (2021: £4,750). Repayments of £2,780 (2021: £nil) were made during the year. At the balance sheet date the outstanding balance was £5,505 (2021: £4,750). The loan is interest free and repayable on demand.
Other related party transactions
At year end the company was owed £11,264 (2021: £11,264) by a company under common control. Due to the concerns over the recoverability of this balance, the directors made the decision to provide in full for the balance during the prior year.
During the year, the company transferred net funding of £1,157 to the parent company. At the year end, the company was owed £2,057 (2021: £900) by the parent company.
The overall controlling party is Mrs A Keeling who owns 100% of the called up share capital of the parent company.